SARS-CoV-2 and the COVID-19 pandemic have changed hematopoietic stem cell transplantation and medical practices worldwide. This is a single-institution cohort of 221 bone marrow recipients at HNERM in Lima, Peru. Patients were transplanted from January 2019 to December 2020. All were maintained under close SARS-CoV-2 vigilance and were followed up until April 2021.We excluded patients who had coronavirus disease prior to transplant. Among patients, 23 (10.4%) developed COVID-19. The detection of the virus based on PCR from nasopharyngeal swabs performed at the presentation of symptoms (fever, cough, and dyspnea) or if clinical/familiar/close contacts with COVID-19 was reported. We analyzed 109 (49.3%) autologous and 66 (29.8%) fully matched related allografts with methotrexate and cyclosporine as GVHD profilaxis and 46 (20.8%) haploidentical allografts with post-transplant cyclophospamide (PTCy). Median age for positive cases was 43.2 years (range 8.7–71.9). M/F ratio was 2/1. Median age for negative cases was 39.4 years (range 3.2–70.3). The median Hematopoietic Comorbidity Index (HCT-CI) score was 1.04 (range 0–5) for SARS-CoV-2-positive cases. COVID-19 disease was more often observed among haplo-identical (7/46, 15.2%), auto-BMT (12/109; 11%) and fully matched related allografts (4/66; 6.06%). Median time from BMT to positive SARS-CoV-2 PCR was 13.3 months (range 5.5–24.5). Six cases each (26%) were multiple myeloma (MM) and lymphoma (L), 5 cases were ALL (21.7%), 4 cases were AML (17.4%), and 1 case each (4.35%) was MDS and autoimmune disease. Most patients developed mild COVID-19 (n=19; 82.6%), with cough, fatigue, and myalgia as frequent symptoms. Severe COVID-19 developed in 4 cases (17.4%) requiring mechanical ventilation, 2 of whom died. Both of the lethal cases were middle-aged men who received auto-BMT for MM and L at 18.57 and 2.43 months after transplant. The HCT-CI scores were 3 and 1. The mortality rate for SARS-CoV-2 positive patients was 8.7%, much higher than among the general population in Peru (2.84%), but less than in HNERM (46.4%). Our cohort showed COVID-19 disease in BMT patients is more frequent in men, similar to the general population. Most of the cases were observed for auto-BMT, specifically among MM and L patients, with similar frequency for both.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.